Gilead Sciences Inc at Barclays Global Healthcare Conference Transcript
Okay. Welcome to the morning session of the Barclays Global Healthcare Conference. My name is Geoff Meacham. I'm the senior biopharma analyst, and have Jason Zemansky here from my team on the podium.
We're thrilled to have Gilead Sciences here. And we have Robin Washington, CFO; and John McHutchison, Head of R&D and CSO.
Questions & Answers
I guess, we'll start with a few commercial questions, and then shift into the pipeline. So Robin, when you look at the Biktarvy launch in the U.S., it's been fantastic. You're new to brand and switch rates have been good. Maybe talk to what you guys view as the upside opportunity from here in the U.S. Is it just more of the same in the U.S.? And then, obviously, we can get into Europe, too.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
